Home
/
Outlook Therapeutics, Inc. (OTLK)
Outlook Therapeutics, Inc. (OTLK) Technical Analysis
Updated: 2026-03-17 00:37 UTC · Last close: 0.35 (-10.69%)
Outlook Therapeutics, Inc. (OTLK) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
Outlook Therapeutics, Inc. (OTLK) closed at 0.35 (-10.69%). Price remains below both the 50-day and 200-day moving averages, which keeps the broader technical backdrop under pressure until stronger recovery signals appear. 20-day momentum is notably weak at -28.18%; price is trading in the lower part of its roughly 52-week range (0.35–2.97); and ATR14 volatility is elevated at roughly 10.03% of price. RSI(14) sits near 31.9, which signals relatively weak momentum conditions. RSI has been drifting lower recently, suggesting that upside momentum may be cooling slightly. MACD is positioned above the signal line, supporting a still constructive momentum backdrop. The MACD histogram remains positive, although upside momentum is not accelerating further. Recent trading volume is running well above its 20-day average, which suggests strong participation behind the latest price moves. On the upside, 0.52 is the nearest resistance area. A cleaner push through that zone would improve continuation potential. Latest fundamentals snapshot: Revenue: 8.15M · Net income: -23.06M · EPS (basic): -0.38. The interactive view adds overlays, pattern context and broader chart structure for deeper review.
Fundamentals Snapshot
Source: sec
Company
Outlook Therapeutics, Inc.
Note: This is an algorithmic technical snapshot (not financial advice).